Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Rite Aid Corp Stock News

RADCQOTC

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.0100

At close: Aug 12, 4:00 PM EDT

$0.00500

-0.00500-50.00%

Pre-Market: Aug 12, 4:00 PM EDT

Rite Aid Corp (RADCQ) Forecast

News

Earnings Rite Aid Corp (RADCQ) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Rite Aid Corp Stock News | OTC:RADCQ | Benzinga

Get the latest news on Rite Aid Corp stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Rite Aid Corp performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, September 03, 2024

Rite Aid Names Matt Schroeder As Chief Execut...
Benzinga Newsdesk - Sep 3, 2024, 12:08PM
Rite Aid Completes Restructuring Process And ...
Benzinga Newsdesk - Sep 3, 2024, 12:04PM

Friday, August 30, 2024

Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
Vandana Singh - Aug 30, 2024, 1:47PM

Thursday, July 25, 2024

Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report
Nabaparna Bhattacharya - Jul 25, 2024, 2:41PM

Monday, July 01, 2024

CVS, Rite Aid, Walgreens Hit Hard By Online Pharmacy Trend
Vandana Singh - Jul 1, 2024, 12:52PM

Thursday, June 27, 2024

Walgreens Plans 'Significant' Store Closures As It Faces 'Difficult Operating Environment'
Michael Juliano - Jun 27, 2024, 1:03PM

Tuesday, June 25, 2024

Judge Rules Against MedImpact In $200M Rite Aid Debt Dispute
Vandana Singh - Jun 25, 2024, 9:54AM

Wednesday, June 12, 2024

Rite Aid, Instacart Expand Partnership To Off...
Benzinga Newsdesk - Jun 12, 2024, 9:04AM

Wednesday, March 27, 2024

Rite Aid Forges Path To Financial Recovery With Major Settlement: Report
Shivani Kumaresan - Mar 27, 2024, 5:54AM

Wednesday, December 13, 2023

Privacy Risks Flagged: Major Pharmacy Chains Share Customer Data With Authorities Without Warrant
Vandana Singh - Dec 13, 2023, 8:58AM

Friday, November 17, 2023

Drugstore Chain Rite Aid Counters DOJ Lawsuit Amid Bankruptcy, Aiming To Safeguard Restructuring
Vandana Singh - Nov 17, 2023, 7:37AM

Wednesday, November 15, 2023

Could Your Eye Drops Be Unsafe? FDA Flags Amazon For Distributing Risky Eye Products, Demands Immediate Action
Nabaparna Bhattacharya - Nov 15, 2023, 6:19AM

Monday, October 30, 2023

GSK's Competitive Edge, Surpasses Pfizer in Respiratory Syncytial Virus Vaccine Sales
Vandana Singh - Oct 30, 2023, 11:48AM
'Pharmageddon' - Thousands Of Pharmacists Plan Walkout To Protest Work Conditions: Report
Shivani Kumaresan - Oct 30, 2023, 11:22AM
Risk of Eye Infection - FDA Issues Strong Warning on Eye Drops from Major Retailers
Vandana Singh - Oct 30, 2023, 9:34AM

Saturday, October 28, 2023

Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
Nabaparna Bhattacharya - Oct 28, 2023, 12:49PM

Thursday, October 19, 2023

Walgreens Agrees To Pay $192.5M To Resolve Rite Aid Buyout Suit: Report
Shivani Kumaresan - Oct 19, 2023, 1:05PM

Tuesday, October 17, 2023

Rite Aid Receives Court Approval Of "First Da...
Benzinga Newsdesk - Oct 17, 2023, 11:07AM

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved